Istanbul Medipol University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Istanbul Turkey (2009)

Organization Overview

First Clinical Trial
2011
NCT05017467
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

AbiliTech Medical Inc. | Ahmet Emir | Ayşegül BOSTAN | Farzin Hajebrahimi, PT, MSc | Health Sciences University | istanbul medipol university | Istanbul Medipol University | IstanbulMedipol University | İstanbul Medipol University, Faculty of Dentistry, Department of Endodontics, Atatürk Bul. No:27, 34083 Unkapanı, Fatih İstanbul/Türkiye | Istanbul Medipol University Hospital | Istanbul Medipol University.Istanbul Medipol University, School of Dentistry Istanbul, Fatih, Turkey, 34083 | Istanbul Medipol University Medical School | İstanbul Medipol Üniversity,Medical School | Medipol University | Mursel Ekinci

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Back Pain (Phase 2)

Dental Pulp Diseases (Phase 4)

Fecal Incontinence (Phase 1)

Fissure in Ano (Phase 4)

Low Back Pain (Phase 2)

Pain, Postoperative (Phase 4)

Parkinson Disease (Phase 2)

Periodontitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 44
  • # of Trial APIs: 44